https://www.biospectrumasia.com/news/54/21185/singapore-pumps-in-sgd19-2-m-for-novel-liver-cancer-treatment-trial.html
0
0
10/6/22 at 7:28am
Organization
Biospectrumasia.com
Authors
Led by the National Cancer Centre Singapore the investigator-initiated, phase 2 clinical trial, across 13 sites in the APAC region, will assess a novel radiotherapy and immunotherapy combination to treat HCC
Create an account
or login to join the discussion